Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults.
Vaccine
; 41(48): 7297-7306, 2023 11 22.
Article
in En
| MEDLINE
| ID: mdl-37925316
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19 Vaccines
/
COVID-19
Limits:
Adult
/
Humans
Language:
En
Journal:
Vaccine
Year:
2023
Type:
Article
Affiliation country:
China